ArticleCancer research2015

PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy.

Chen-Lin Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.